
Scientist I
KBI Biopharma
Summary
KBI Biopharma seeks a scientist to join our Analytical and Formulation Sciences (AFS) team in Louisville, CO. This role befits a scientist with expertise in large or small molecule biochemistry techniques—e.g. high performance liquid chromatography (HPLC), spectroscopy (UV/VIS/IR), electrophoresis, and formulation development. Prior mass spectrometry experience is not required but may be beneficial. You will serve as a subject matter expert (SME), driving innovation and excellence in analytical testing to support client programs from early development through late-phase and commercialization for biotherapeutics.
Job description
Position Responsibilities
- Self-motivation to pursue short- to medium-term project objectives.
- Expertise in execution and interpretation of experiments that contribute to project goals.
- Expertise in biochemistry techniques including HPLC, spectroscopy (UV/VIS/IR), capillary electrophoresis (SDS-CGE, iCIEF).
- Experience optimizing multiple chromatographic modalities—e.g. SEC, RP, HILIC, and CEX.
- Familiarity with Waters and Agilent U(H)PLC systems.
- Occasional execution of LC-MS methods—e.g. intact protein, peptide mapping, oligonucleotides, and small molecules.
- Design and strategically execute analytical experiments in support of biotherapeutics development, particularly qualification/validation and stability studies.
- Generate high-quality documentation suitable for publication and regulatory review, including technical documents and analytical test methods.
- Act as SME on client programs, providing technical guidance and representing KBI in client interactions.
- Collaborate cross-functionally with rapid analytics, process development, bioassay, and program management teams.
- Mentor and train junior scientists and associates.
- Perform peer review of data and reports related to method development, qualification, and validation, as well as characterization and stability study reports.
- Manage timelines and resources to meet project milestones and proactively advise leadership on program status and technical challenges.
Minimum Requirements
- Ph.D. in Biochemistry, Analytical Chemistry, or a related field with 0-3 years experience; M.S. with 3-7 years experience; B.S. degree with >7 years experience.
- Adaptability to changing priorities and business needs.
- Adherence to statutory and company safety requirements.
- Strong understanding of strengths and weaknesses of techniques to evaluate biochemical properties of proteins and small molecules.
- Excellent communication skills and ability to present complex data to diverse audiences.
- Proficiency in scientific software and data analysis tools (e.g. Excel, Prism).
- Ability to work independently and collaboratively in a fast-paced environment.
Requirements
- Ph.D. in Biochemistry, Analytical Chemistry, or a related field with 0-3 years experience; M.S. with 3-7 years experience; B.S. degree with >7 years experience
- Expertise in biochemistry techniques including HPLC, spectroscopy (UV/VIS/IR), capillary electrophoresis (SDS-CGE, iCIEF)
- Experience optimizing multiple chromatographic modalities—e.g. SEC, RP, HILIC, and CEX
- Familiarity with Waters and Agilent U(H)PLC systems
- Strong understanding of strengths and weaknesses of techniques to evaluate biochemical properties of proteins and small molecules
- Excellent communication skills and ability to present complex data to diverse audiences
- Proficiency in scientific software and data analysis tools (e.g. Excel, Prism)
- Ability to work independently and collaboratively in a fast-paced environment
- Adaptability to changing priorities and business needs
- Adherence to statutory and company safety requirements
Company overview
KBI Biopharma is an award-winning global contract development and manufacturing organization (CDMO) that provides fully integrated, accelerated drug development and biologics manufacturing services to pharmaceutical and biotechnology companies worldwide. Founded in 1996 and now part of JSR Life Sciences, KBI has established itself as a next-generation CDMO specializing in complex biologics. The company serves over 500 client partners and has supported the advancement of more than 160 drug candidates from preclinical stages to market, including the manufacture of ten commercial products. KBI's comprehensive service portfolio includes cell line development, process development, analytical services, formulation development, and clinical and commercial cGMP manufacturing for both mammalian and microbial programs. With strategically located facilities across the United States and Europe, KBI leverages world-class analytical capabilities and proprietary platforms like SUREtechnology™ and PUREplatform™ to deliver personalized, accelerated solutions for biopharmaceutical development. The company is recognized for its scientific excellence, quality manufacturing, and commitment to helping clients bring innovative medicines to patients faster.